Search

In present research the action of coenzyme Q10 on energetic metabolism and antioxidant system at different temperature conditions has been studied. It was established that the addition of coenzyme Q10 caused inadequate stimulation of main metabolic systems that could lead to running out of functional reserves of cardiomyocytes. The use of coenzyme Q10 helped to optimize intracellular compensating mechanisms supplying the defense of myocardium. Introduction in a diet coenzyme Q10 in conditions of a temperature's comfort threshold excess and development of a histic hypoxia can promote the decrease of gravity of hypoxic myocardium's lesions and to glycogenolysis' amplification that promotes maintenance of an energy homeostasis of a myocardium in posthypoxia term. It is possible to assume, that the augmentation of duration of reception coenzyme Q10 or its dosages can render more expressed protective effect.

Estimation and analytical methods were employed to investigate real rations of patients with gastroduodenal ulcer. Chemical composition of diet N 1 was found unsatisfactory both by ascorbic acid and carbohydrates content responsible for low-caloric value of the diet. The ration correction with additional provision of vegetables, fruit, greens raised vitamin C intake by the patients though the deficiency was not abolished.

The content of ascorbin acid and thiamin was assessed in the food ration of 36 patients with chronic gastritis and ulcer disease. By the end treatment including dietotherapy these vitamins showed a deficit. Correction of this deficit of the above mentioned vitamins with a polyvitamine drug "Supradin" allowed to improve significantly the biochemical indices and availability of ascorbic acid and thiamin in patients with chronic gastritis and ulcer disease. The treatment produced a favourable effect on the clinical course of the disease, reduction of the pain syndrome and earlier recovery.

A hygienic evaluation has been presented of fish bred in pools and treated with commercial crotopolactone for the therapy and prevention of aeromonosis, which was not previously used for this purpose. Basing on the study of the residual amounts of crotonolactone in the fish, of the organoleptic properties, chemical composition and biological value of the fish, as well as on the results of a chronic (12 months) experiment on test animals, the authors have made a conclusion on the possibility of using this fish as food for humans. Certain doses of commercial crotonolactone are recommended for the treatment of aeromonosis in fish.